Schwannoma surgery: Difference between revisions
No edit summary |
|||
Line 39: | Line 39: | ||
OR | OR | ||
*Surgery is the mainstay of treatment for [disease or malignancy]. | *Surgery is the mainstay of treatment for [disease or malignancy]. | ||
* | |||
{| class="wikitable" | |||
|+Indications, benefits and disadvantages of lateral skull base approaches for VS resection. | |||
! | |||
!'''Translybyrinthine''' | |||
!'''Retrosigmoid''' | |||
!'''Middle fossa''' | |||
|- | |||
|Indications | |||
|Non-serviceable hearing; any IAC or CPA VS | |||
|VS with large CPA component; medial IAC VS | |||
|Small lateral IAC VS (<0.5 cm); small medial IAC VS with < 1 cm CPA component | |||
|- | |||
|Advantages | |||
|Minimal brain retraction | |||
|Panoramic CPA exposure; better facial nerve and hearing preservation for medial VS | |||
|Better exposure lateral IAC | |||
|- | |||
|Disadvantages | |||
|Complete hearing loss; difficult approach for CPA VS ventral to porus acusticus; risk for facial nerve injury | |||
|Limited access to lateral IAC; potential for cerebellar and brainstem injury | |||
|Limited PF access; temporal lobe retraction; risk for facial nerve injury | |||
|} | |||
==Contraindications== | ==Contraindications== |
Revision as of 23:08, 27 October 2019
Schwannoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Schwannoma surgery On the Web |
American Roentgen Ray Society Images of Schwannoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].
Translybyrinthine | Retrosigmoid | Middle fossa | |
---|---|---|---|
Indications | Non-serviceable hearing; any IAC or CPA VS | VS with large CPA component; medial IAC VS | Small lateral IAC VS (<0.5 cm); small medial IAC VS with < 1 cm CPA component |
Advantages | Minimal brain retraction | Panoramic CPA exposure; better facial nerve and hearing preservation for medial VS | Better exposure lateral IAC |
Disadvantages | Complete hearing loss; difficult approach for CPA VS ventral to porus acusticus; risk for facial nerve injury | Limited access to lateral IAC; potential for cerebellar and brainstem injury | Limited PF access; temporal lobe retraction; risk for facial nerve injury |
Contraindications
References